Pierre Vande Perre

Institut Claudius Regaud

France

Research Interests

Explore related searches

Professors in France Professors in Cancer Biology Cancer Biology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Collaborators (7)

Paul Kuentz

Professeur des Universités-Praticien Hospitalier

Centre Hospitalier Universitaire Vaudois

FRANCE

View details

Richard Redon

INSERM

FRANCE

View details

Louise-Marie CHEVALIER

Institut de Cancérologie de l'Ouest

FRANCE

View details

Caroline Rooryck

University of Bordeaux

FRANCE

View details

Eric Pasmant

Head

Institut Curie

FRANCE

View details

Sarah Baer

Chief of resident

Hôpitaux universitaires de Strasbourg

FRANCE

View details

Hélène Cavé

PUPH, Head of the molecular Genetics unit

Hôpital Robert-Debré

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pierre Vande Perre

Research Interests

Explore related searches

Contact this professor

Articles (8)

<i>PFMG2025</i>-integrating genomic medicine into the national healthcare system in France.

Deciphering dual clinical entities associated with <scp><i>TP53</i></scp> pathogenic variants: Insights from 53,085 <scp>HBOC</scp> panel analyses in French laboratories

Germline Sequencing of Familial and Sporadic Early-Onset Colorectal Cancer: A Novel Pattern of Genes

Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients.

Special features of sarcomas developed in patients with Lynch syndrome: A systematic review.

The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity.

An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes.

Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

Collaborators (7)

Paul Kuentz

Richard Redon

Louise-Marie CHEVALIER

Caroline Rooryck

Eric Pasmant

Sarah Baer

Hélène Cavé

Make your next move.

Pierre Vande Perre

Research Interests

Explore related searches

Contact this professor

Articles (8)

&lt;i&gt;PFMG2025&lt;/i&gt;-integrating genomic medicine into the national healthcare system in France.

Deciphering dual clinical entities associated with <scp><i>TP53</i></scp> pathogenic variants: Insights from 53,085 <scp>HBOC</scp> panel analyses in French laboratories

Germline Sequencing of Familial and Sporadic Early-Onset Colorectal Cancer: A Novel Pattern of Genes

Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients.

Special features of sarcomas developed in patients with Lynch syndrome: A systematic review.

The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity.

An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes.

Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

Collaborators (7)

Paul Kuentz

Richard Redon

Louise-Marie CHEVALIER

Caroline Rooryck

Eric Pasmant

Sarah Baer

Hélène Cavé

Make your next move.

<i>PFMG2025</i>-integrating genomic medicine into the national healthcare system in France.